| 181/425 | US=10 / Urologia Beekman KW, Buchanan G, Tilley WD, Scher HI. Antiandrogen withdrawal syndromes: pathophysiology and clinical implications. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 317-25. ISBN 978-0415-458933-1. |
| 182/425 | US=10 / Urologia Armstrong AJ, Carducci MA. Chemotherapy for advanced prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 327-39. ISBN 978-0415-458933-1. CANCER DE PROSTATA; QUIMIOTERAPIA; HORMONIO-REFRATARIO; AGENTES BIOLOGICOS |
| 183/425 | US=10 / Urologia Song DY, Jabbour SK, DeWeese TL. Radiotherapy for the treatment of locally advanced and metastatic prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 341-57. ISBN 978-0415-458933-1. |
| 184/425 | US=10 / Urologia Kirby RS, Coxon JP. Use of bisphosphonates in the management of osseous metastases. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 359-64. ISBN 978-0415-458933-1. |
| 185/425 | US=10 / Urologia Kirby RS. Managing the complications of advanced prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 365-74. ISBN 978-0415-458933-1. CANCER DE PROSTATA; COMPLICACOES; TRATO URINARIO INFERIOR; UROPATIA OBSTRUTIVA; COMPRESSAO DA MEDULA ESPINHAL |
| 186/425 | US=10 / Urologia Newling D. Principles of palliative care and psychosocial support of the metastatic prostate cancer patient. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 375-8. ISBN 978-0415-458933-1. CANCER DE PROSTATA; CUIDADOS PALIATIVOS; APOIO PSICOSSOCIAL; TERAPIA ANTINEOPLASICA; MANEJO DA DOR |
| 187/425 | US=10 / Urologia Assikis VJ, Jonas W, Simons JW. The promise of immunotherapy in prostate cancer: from concept to reality. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 379-88. ISBN 978-0415-458933-1. CANCER DE PROSTATA; IMUNOTERAPIA; VACINA; TECNOLOGIA DE TRANSFERENCIA GENETICA; IMUNOTERAPIA ATIVA; CITOCINAS; IMUNOTERAPIA PASSIVA |
| 188/425 | US=10 / Urologia Kirby M. Role of the primary care professional in the care of the patient with prostate cancer: a UK perspective. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 389-94. ISBN 978-0415-458933-1. CANCER DE PROSTATA; CUIDADO DO PACIENTE; PERSPECTIVA; DIAGNOSTICO; TRIAGEM |
| 189/425 | US=10 / Dor/Paliativo McClurg D, McCabe P, Chambers K. Multi-professional management of genitourinary tumours: gynaecological and prostate. In: Rankin J, Robb K, Murtagh N, Cooper J, Lewis S. Rehabilitation in cancer care. New York: John Wiley & Sons, 2008. p. 213-40. ISBN 978-1-4051-5997-5. TUMORES GENITURINARIOS; CANCERES GINECOLOGICOS; CANCER DE PROSTATA |
| 190/425 | US=8 / UTI Antoniazzi P, Sadala P, Santiago E. Cistotomia. In: Guimarães HP, Falcão LFR, Orlando JMC, editores. Guia prático de UTI. São Paulo: Athenue, 2009. p. 221-8. ISBN 85-7379990-3. CISTOTOMIA; CISTOTOMIA POR PUNCAO SUPRAPUBICA; CISTOTOMIA POR INCISAO SUPRAPUBICA; CISTITE INTERTICIAL REFRATARIA; TUBERCULOSE UROGENITAL; HIPERPLASIA PROSTATICA BENIGNA GRAVE; RETENCAO URINARIA AGUDA; CALCULO IMPACTADO; ESTENOSE GRAVE DE URETRA; VALVULA DE URETRA POSTERIOR; CARCINOMA URETRAL; CANCER DO COLO UTERINO; ADENOCARCINOMA DE PROSTATE; PROSTATITE BACTERIANA AGUDA; TRAUMAS URETRAIS; TRAUMAS URETRAIS IATROGENICOS; TRAUMA VESICAL; OBSTRUCAO POR ENDOMETRIOSE |
| 191/425 | US=110 / Câncer Nelson WG, Carter B, DeWeese T, Eisenberger MA. Prostate cancer. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 1653-99. ISBN 978-0-443-06695-5. |
| 192/425 | US=13 / Estatística Mucci LA, Signorello LB, Adami HO. Prostate cancer. In: Adami HO, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. 2nd ed. Oxford: University Press, 2008. p. 517-54. (Monographs in Epidemiology and Biostatistics) ISBN 978-0-19-531117-4. |
| 193/425 | US=14 / Câncer Plowman PN. Recent london improvements in curative radiation therapy for relevant early prostate cancer. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 257-66. ISBN 978-1-57331-700-9. |
| 194/425 | US=14 / Radioterapia Chung HT. Prostate cancer. In: Lu JJ, Brady LW. Radiation oncology: an evidence-based approach. New York: Springer, 2008. p. 299-319. (Medical radiology: diagnosis imaging and radiation oncology series editors; AL Baert, LW Brady, HP Heilmann, Knauth M, M Molls, C Nieder) ISBN 978-3-540-77384-9. CANCER DE PROSTATA; CANCER DE PROSTATA LOCALIZADO. TRATAMENTO |
| 195/425 | US=25 / Urologia Sakr W. Defining the problem: from subclinical disease to clinically insignificant prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 1-11. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. |
| 196/425 | US=25 / Urologia Stamey TA, Nolley R, Torti D. What every patient should know about prostate cancer before he submits to biopsy of his prostate. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 13-27. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. |
| 197/425 | US=25 / Urologia Nielsen ME, Partin AW. The role of complexed prostate-specific antigen in prostate cancer screening. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 29-41. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. PAPEL DO COMPLEXADO ANTIGENO PROSTATICO; RASTREAMENTO DO CANCER DE PROSTATA; ISOFORMAS DE PSA; COMPLEXADO POR CENTO PSA PSA LIVRE |
| 198/425 | US=25 / Urologia Canto EI, Slawin KM. Newly recognized forms of prostate-specific antigen and emerging molecular markers. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 43-59. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. ANTIGENO PROSTATICO ESPECIFICO; EMERGENTES MARCADORES MOLECULARES; ANTIGENO ESPECIFICO DA PROSTATA (PSA); FORMAS MOLECULARES DE PSA LIVRE; RASTREIO DO CANCER DA PROSTATA; MALDI-TOF; SELDI-TOF |
| 199/425 | US=25 / Urologia Carter HB. The role of prostate-specific antigen velocity in the diagnosis and management of prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 61-70. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. PROSTATICO ESPECIFICO; TRATAMENTO DE CANCER DE PROSTATA; BLINDAGEM; VELOCIDADE DO PSA; PSA TEMPO DE DUPLICACAO; PSA CINETICA |
| 200/425 | US=25 / Urologia Brand TC, Thompson IM. Prostate cancer screening: navigating the controversy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 71-82. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. RASTREIO DO CANCER DA PROSTATA; CANCER DE PROSTATA; ANTIGENIO ESPECIFICO DA PROSTATA; PREVENCAO |